Thursday, April 16, 2026

KG Mobility Reports 11.4% Global Sales Drop in March, Despite Export Growth

KG Mobility's global sales fell 11.4% in March, despite a 4.6% rise in exports, due to a 31.8% drop in South Korean sales.

BMW Rolls Out Luxury on All Cylinders with New Korea-Exclusive Editions

BMW Korea launches four limited-edition models for its 30th anniversary, showcasing luxury, performance, and unique designs.

Discover the Excellence of Botulax and Revolax at Thailand’s Largest Dermatology Conference

Hugel showcased its HA filler Revolax and botulinum toxin products at Thailand's largest dermatology conference, enhancing medical engagement.

Daewoong Pharmaceutical holds “Nabota Master Class,” demonstrates proprietary procedures

HealthDaewoong Pharmaceutical holds “Nabota Master Class,” demonstrates proprietary procedures
Group photo of medical professionals participating in “NMC Spring in Korea.” / Courtesy of Daewoong
Group photo of medical professionals participating in “NMC Spring in Korea.” / Courtesy of Daewoong

Daewoong Pharmaceutical (069620) said on the 16th it successfully held its global academic program, “Nabota Master Class (NMC) Spring in Korea,” for medical professionals.

The event was held from April 13 to 15 at multiple venues, including Mercure Seoul Magok, COEX Magok, Ewha Womans University Seoul Hospital and Daewoong Pharmaceutical’s Hyangnam plant, with 74 medical professionals from 13 countries, including Thailand, Brazil and Chile, in attendance.

Centered on the brand message “SAFETY ON, BEAUTY ON,” Daewoong Pharmaceutical conducted a range of programs from academic sessions to production facility tours.

In particular, Nabota’s proprietary procedures, NABOLIFT and NABOGLOW, shared practical know-how and experience that can be applied in real clinical settings.

A tour of Daewoong Pharmaceutical’s Hyangnam plant was also one of the key programs. Medical professionals toured major facilities at both the existing and new plants, directly reviewing Nabota’s quality control system and production infrastructure.

Through experiences involving aseptic processes, key production equipment and automated logistics systems, participants observed the manufacturing competitiveness supporting Nabota’s safety and reliability.

Yoon Joon-soo, head of Daewoong Pharmaceutical’s Nabota Business Division, said, “Daewoong Pharmaceutical will continue to strengthen its brand competitiveness and global leadership through a differentiated global academic platform that expands Nabota’s proprietary procedures and clinical experience.”

Check Out Our Content

Check Out Other Tags:

Most Popular Articles